Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cesca Therapeutics appoints Denis Rhein to board

This article was originally published in Scrip

Executive Summary

California-based Cesca Therapeutics, an autologous cell-based regenerative medicine company, has named Mr Denis Michael Rhein to its board of directors. Mr Rhein is the founder and director of EMR Vermögensverwaltung, an investment management company and the founder, principal shareholder and director of Illumisound, an alternative energy efficient commercial lighting company. He also has over 30 years of corporate banking and securities experience at Deutsche Bank in Frankfurt, Germany.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts